Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US nod for Lynparza in HRD-positive advanced ovarian cancer

pharmatimesMay 12, 2020

Tag: Lynparza , ovarian cancer , AstraZeneca , msd , Enhertu

PharmaSources Customer Service